| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| S-(5-氨基-1,2-二甲基-1H-咪唑-4-基)-L-半胱氨酸 | L-Cysteine, S-(5-amino-1,2-dimethyl-1H-imidazol-4-yl)- | 91260-85-4 | C8H14N4O2S |
| S-(5'-腺苷)-L-高半胱氨酸 | S-(5'-adenosyl)-L-homocysteine | 979-92-0 | C14H20N6O5S |
| S-(4-甲基苯基)-2-甲基-5-苯基吡啶-3-硫代甲酸酯 | (4-methylphenyl) 2-methyl-5-phenylpyridine-3-carbothioate | 917882-52-1 | C20H17NOS |
| S-(4-叔-丁基苯甲基)(2-butylpyridin-3-yl)硫代氨基甲酸酯 | 3a,4,5,6-Tetrahydro-1,1,3-trimethylindancarbaldehyde | 97999-29-6 | C13H20O |
| S-(2-氯-1,1,2-三氟乙基)谷胱甘肽 | S-(2-Chloro-1,1,2-trifluoroethyl)glutathione | 97058-30-5 | C12H17ClF3N3O6S |
| S-(11-溴十一烷基)硫代乙酸酯 | S-(11-bromoundecyl) ethanethioate | 947150-46-1 | C13H25BrOS |
| S-(1,2-二氯乙烯)谷胱甘肽 | (E)-S-(1,2-dichlorovinyl)glutathione | 96614-59-4 | C12H17Cl2N3O6S |
| S-(1,2,3-三氯乙烯)半胱氨酸 | S-(1,2,2-trichlorovinyl)-L-cysteine | 98025-31-1 | C5H6Cl3NO2S |
| S-(1,1,2,2,3,3-六氟丙基)-L-半胱氨酸 | S-(1,1,2,2,3,3-Hexafluoropropyl)-L-cysteine | 98640-41-6 | C6H7F6NO2S |
| S-(-)-阿替洛尔 | (S)-Atenolol | 93379-54-5 | C14H22N2O3 |
| S-(-)-比索洛尔 | (S)-bisoprolol | 99103-03-4 | C18H31NO4 |
| S-(-)-依替必利盐酸盐 | Eticlopride hydrochloride | 97612-24-3 | C17H25ClN2O3*ClH |
| S-(-)-N-丙基-2-氯甲基吡咯烷盐酸盐 | S-(-)-N-propyl-2-chloromethylpyrrolidine hydrochloride | 96721-76-5 | C8H16ClN*ClH |
| S-(+)-美西律 | (S)-mexiletine | 94991-72-7 | C11H17NO |
| Rosebengal二(三乙基铵)盐 | Rose bengal bis(triethylamine) | 91491-51-9 | C32H34Cl4I4N2O5 |
| RO5126766(CH5126766)抑制剂 | VS-6766 | 946128-88-7 | C21H18FN5O5S |
| RENIN人 | renin | 9015-94-5 | —— |
| RECILISIBSODIUM(钠盐) | Ex-RAD | 922139-31-9 | C16H12ClO4S*Na |
| RAC去甲基西酞普兰盐酸 | Desmethylcitalopram hydrochloride | 97743-99-2 | C19H19FN2O*ClH |
| R788中间体4 | ditert-butyl [6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxo-pyrido[3,2-b][1,4]oxazin-4-yl]methyl phosphate | 901119-38-8 | C31H42FN6O9P |
| R7128;(2'R)-2'-去氧-2'-氟-2'-甲基胞苷3',5'-双(2-甲基丙酸)酯 | (2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-4-fluoro-2-((isobutyryloxy)methyl)-4-methyltetrahydrofuran-3-yl isobutyrate | 940908-79-2 | C18H26FN3O6 |
| R-阿法替尼 | 4-[(3-chloro-4-fluorophenyl)amino]-6-{[4-(N,N-dimethylamino)-1-oxo-2-buten-1-yl]amino}-7-((R)-tetrahydrofuran-3-yloxy)-quinazoline | 945553-91-3 | C24H25ClFN5O3 |
| R-盐酸普拉克索 | Dexpramipexole dihydrochloride | 908244-04-2 | C10H21Cl2N3OS |
| R-哌啶-3-羧酸叔丁酯 | tert-butyl (R)-nipecotate | 912807-35-3 | C10H19NO2 |
| R-α,α-双(3,5-二三氟甲基苯基)脯氨醇三甲基硅醚 | (R)-α,α-bis[3,5-bis(trifluoromethyl)phenyl]-2-pyrrolidinemethanol trimethylsilyl ether | 908303-26-4 | C24H23F12NOSi |
| R-VANOL磷酸酯 | VANOL phosphate | 956610-76-7 | C32H21O4P |
| R-N,N'-二苄基联萘胺 | (+)-(R)-2,2'-bis(benzylamino)-1,1'-binaphthyl | 96948-51-5 | C34H28N2 |
| R-3,3'-二(三苯基硅基)联萘酚膦酸酯 | (R)-3,3'-bis(triphenylsilyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate | 929097-92-7 | C56H41O4PSi2 |
| R-106583(普拉格雷代谢物) | R-106583 | 916599-27-4 | C19H22FNO3S |
| R-1-N-BOC-2-氰基哌啶 | 1,1-dimethylethyl (2R)-2-cyano-1-piperidinecarboxylate | 940000-26-0 | C11H18N2O2 |
| R-1-Cbz-3-甲基氨基-吡咯烷 | Benzyl (3R)-3-(methylamino)pyrrolidine-1-carboxylate | 917459-77-9 | C13H18N2O2 |
| R-1-1H-3-苄氧基吡咯烷盐酸盐 | (R)-3-(benzyloxy)pyrrolidine hydrochloride | 927819-90-7 | C11H15NO*ClH |
| R-(+)-3-(氨基甲酰基甲基)-5-甲基己酸钠盐 | R-(+)-3-(carbamoylmethyl)-5-methylhexanoic acid sodium salt | 959688-09-6 | C9H16NO3*Na |
| R-(+)-2-(4-羟苯氧基)丙酸甲酯 | methyl (R)-(+)-2-(4-hydroxyphenoxy)propionate | 96562-58-2 | C10H12O4 |
| R(+)月桂K8644 | methyl (4R)-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate | 98791-67-4 | C16H15F3N2O4 |
| Ptelatoside B; 4-乙烯基苯基 2-O-(6-去氧-alpha-L-吡喃甘露糖)-beta-D-吡喃葡萄糖苷 | ptelatoside-B | 90852-99-6 | C20H28O10 |
| Phenoprol胺盐酸盐 | Phenoprolamine Hydrochloride | 93933-71-2 | C21H30ClNO3 |
| Palmitoleoy乙醇胺 | Palmitoleoyl Ethanolamide | 94421-67-7 | C18H35NO2 |
| PYRAZOLOACRIDINE无结构图 | Pyrazoloacridine methanesulfonate | 99009-21-9 | CH4O3S*C19H21N5O3 |
| PROTACBET结合部分2 | (S)-4-(4-chlorophenyl)-6-(2-methoxy-2-oxoethyl)-3,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-2-carboxylic acid | 916493-82-8 | C20H17ClN4O4S |
| POLO-LIKEKINASE1抑制剂 | GSK461364 | 929095-18-1 | C27H28F3N5O2S |
| PFBOA-丙醛 | Propionaldehyde O-pentafluorophenylmethyl-oxime | 932710-53-7 | C10H8F5NO |
| PF750;N-苯基-4-(3-喹啉基甲基)-1-哌啶甲酰胺 | N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide | 959151-50-9 | C22H23N3O |
| PF03716556;8-[[(4R)-3,4-二氢-5-甲基-2H-1-苯并吡喃-4-基]氨基]-N-(2-羟基乙基)-N,2-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺 | N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-1-benzopyran-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide | 928774-43-0 | C22H26N4O3 |
| PF-3274167抑制剂 | (5-(3-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-5-(methoxymethyl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridine) | 900510-03-4 | C19H19ClFN5O3 |
| PF 562271 苯磺酸盐; N-甲基-N-[3-[[[2-[(2-氧代-2,3-二氢-1H-吲哚-5-基)氨基]-5-三氟甲基嘧啶-4-基]氨基]甲基]吡啶-2-基]甲磺酰胺苯磺酸盐 | N-methyl-N-(3-((2-(2-oxoindolin-5-ylamino)-5-(trifluoromethyl)pyrimidin-4-ylamino)methyl)pyridin-2-yl)methanesulfonamide benzenesulfonate | 939791-38-5 | C6H6O3S*C21H20F3N7O3S |
| PF 04217903; 2-[4-[1-(喹啉-6-甲基)-1H-[1,2,3]三唑并[4,5-b]吡嗪-6-基]-1H-吡唑-1-基]乙醇 | PF-04217903 | 956905-27-4 | C19H16N8O |
| PF 04217903 甲磺酸盐; 4-[1-(6-喹啉基甲基)-1H-1,2,3-三唑并[4,5-b]吡嗪-6-基]-1H-吡唑-1-乙醇甲磺酸盐 | PF04217903 | 956906-93-7 | CH4O3S*C19H16N8O |
| PEG NHS 酯二硫醚 | SS-PEG-NHS ester | 947601-98-1 | C46H80N2O24S2 |
| PEFICITINIB游离态 | Peficitinib | 944134-74-1 | C18H22N4O2 |